During development, ribosome biogenesis and translation reach peak activities, due to impetuous cell proliferation. Current models predict that protein synthesis elevation is controlled by transcription factors and signalling pathways.
INTRODUCTION
During cell proliferation, ribosomal proteins (RPs) and eukaryotic Initiation Factors (eIFs) are necessary and in high demand for ribosome biogenesis and translation [1] [2] [3] [4] [5] .
Proteins involved in ribosome biogenesis do not usually have a role in the translational control and vice versa 6 . However, the eukaryotic Initiation Factor 6 (eIF6) is remarkably unique 7 : a nuclear pool is essential for nucleolar maturation of the 60S large subunit 8 , while cytoplasmic eIF6 acts as a translation factor.
Mechanistically, eIF6 is an anti-association factor: by binding to the 60S subunit, eIF6 prevents its premature joining with a 40S not loaded with the preinititiaton complex. Release of eIF6 is then mandatory for the formation of an active 80S 9 . In mammals, eIF6 translation activity increases fatty acid synthesis and glycolysis through translation of transcription factors such as CEBP/β, ATF4 and CEBP/δ containing G/C rich or uORF sequences in their 5'UTR 10, 11 . The dual action of eIF6 in ribosome biogenesis and translation suggests that it may act as a master gene regulating ribosomal efficiency. Remarkably, point mutations of eIF6 can revert the lethal phenotype of ribosome biogenesis factors such as SBDS 12 and eFL1p 13 . eIF6
is highly conserved in yeast, Drosophila and humans 14 . During evolution, the eIF6 gene has not been subjected to gene duplication. Despite its ubiquitous role, eIF6 levels in vivo are tightly regulated, showing considerable variability of expression among different tissues 15 . Importantly, high levels of eIF6 or hyperphosphorylated eIF6 are observed in some cancers 16, 17 . eIF6 is rate-limiting for tumor onset and progression in mice 18 . In addition, eIF6 amplification is observed in luminal breast cancer patients 19 and may affect also cancer cell migration 20, 21 . However, whether eIF6 overexpression per se can change a transcriptional program in the absence of other genetic lesions is unknown.
To determine the effects of eIF6 increased gene dosage in vivo, we took advantage of Drosophila melanogaster, an ideal model to manipulate gene expression in a time and tissue-dependent manner, using the GAL4/UAS system 22, 23 . We reasoned that a gain of function approach could allow us to evaluate the effects of eIF6 overexpression in the context of an intact organ. To this end, we used the fly eye, an organ not essential for viability, whose development from epithelial primordia, the larval eye imaginal disc, is well understood. The adult fly compound eye is a stunningly beautiful structure of approximately 800 identical units, called ommatidia 24 .
Each ommatidium is composed of eight neuronal photoreceptors, four glial-like cone cells and pigment cells 25, 26 . By increasing eIF6 levels in the eye, we have found alterations in physiological apoptosis at the pupal stage, correlating with an increase in general translation. Importantly, we also observed a reshaping of the eye transcriptome that revealed a coordinated downregulation of the ecdysone biosynthesis pathway. Overall, our study provides the first in vivo evidence that an increase in translation, dependent on a heightened eIF6 gene dosage, may drive metabolic changes and a transcriptional rewiring of a developing organ. Our model shows that overexpression of a translation factor per se induces a gene expression program and stresses the central role of translational control.
RESULTS

Increased eIF6 levels cause embryonic lethality and aberrant morphology
Regulation of eIF6 levels is stringent in normal conditions 15 with evidence for eIF6 amplification 19 and overexpression in cancer 14, 16, [27] [28] [29] . We used the Drosophila melanogaster model to establish whether an increased dosage of eIF6 could drive specific developmental decisions.
We first assessed the effects caused by the loss of the Drosophila homologue of eIF6. To this end, we used the P element allele eIF6 k13214 30 , inducing mitotic clones homozygous for eIF6 k13214 in first instar larvae by heat shock-induced FLIP/FLPmediated homologous recombination 31 . We did not observe clones of eIF6 mutant cells with the exception of small ones in the wing margin. Similar results were obtained in a minute (M) background that provides a growth advantage to mutant cells, or by targeted expression of FLP in the wing margin ( Supplementary Fig. 1a ).
Together, these results indicate that eIF6 is required for cell viability in Drosophila, as previously observed in yeast 17 and mammals 8 , precluding significant studies on the effects of eIF6 inhibition, a phenomenon anyhow absent in physiological conditions.
Next, we assessed the effects of eIF6 gain of function, which is often observed in several cancers, by expressing eIF6 ubiquitously using the TubGAL4 driver. Ectopic expression resulted in late embryonic lethality ( Supplementary Fig. 1b ), suggesting that increased levels of eIF6 dramatically disrupt gene expression. To circumvent early lethality, we then focused on a non-essential fly organ, the eye. Increased eIF6 expression during late larval eye disc development, driven by the GMRGAL4 driver (GMR>eIF6), causes the formation of a reduced and rough adult eye (Fig. 1a) . Using a new antibody specific for Drosophila eIF6 that we developed (see Material and
Methods section) we estimated that the level of expression was about doubled compared to controls (Fig. 1b) . SEM analysis showed severe disruption of the stereotypic structure of the wild-type eye, with flattened ommatidia and bristles arranged in random patterns (Fig. 1c) . Semithin sections evidenced that the phenotype correlates with an aberrant arrangement and morphology of the eye cells (Fig. 1d) . These data show that doubling the eIF6 gene dosage in the Drosophila eye causes disruption of eye development.
Increased eIF6 gene dosage delays physiological apoptosis
To understand the origin of the defects observed in GMR>eIF6 adult eyes, we analyzed eye development in larvae, starting from the third instar, the stage at which the GMR-GAL4 driver starts to be expressed. We found that third instar imaginal discs with higher levels of eIF6 showed no differences in terms of morphology or cell identity, when compared to controls ( Supplementary Fig. 2a ). Then, we analyzed pupal development. In GMR>eIF6 flies at 40h after puparium formation (APF) both neuronal and cone cells were present in the correct numbers. However, ommatidial morphology was altered ( Supplementary Fig. 2b ). We considered that a fundamental event controlling ommatidial morphology is the developmentally-controlled wave of Programmed Cell Death (PCD), sweeping the tissue from 25h to 42h APF 26 . Thus, we analyzed by immunostaining the expression of Drosophila apoptotic effector caspase Dcp-1, as a marker of PCD, at 40h APF. Control retinae showed clear presence of apoptotic cells. Remarkably, apoptotic cells were completely absent in GMR>eIF6 retinae (Fig. 2a) .
Dcp-1 positive cells, i.e. apoptotic cells, appeared in GMR>eIF6 retinae only at 60h APF (Fig. 2b) . In contrast, 60h APF wild-type retinae did not show any longer apoptotic cells (Fig. 2b) . Quantitation of the number of Dcp-1 positive cells at 40h
APF and 60h APF in GMR>eIF6 (Fig 2c) revealed up to 75% reduction in the number of apoptotic cells at 40h APF. A change in apoptosis dynamics was also visualized by TUNEL assay at 28h APF, the time at which PCD starts in control retinae. Here, we observed the absence of apoptotic nuclei in the GMR>eIF6 retinae, while GMRGAL4/+ retinae showed several ( Supplementary Fig. 2c ). We stained for the Drosophila β-catenin homologue Armadillo (Fig. 3 Supplementary Fig. 3a ). Later in development, both at 60h and at 72h APF, in GMR>eIF6 retinae Armadillo was no longer detectable, while in wild-type retinae the pattern of Armadillo was maintained ( Fig. 3b and Supplementary Fig. 3b ).
These data indicate that late PCD in GMR>eIF6 is likely to inappropriately remove most inter-ommatidial cells (IOCs). In conclusion, the first effect of eIF6 high levels is not a cytotoxic effect, but a block of apoptosis that leads in turn to a disrupted developmental program.
Increased eIF6 dosage in cone cells is sufficient to delay apoptosis
Cone cells and IOCs are known to be the main actors during physiological PCD 32 .
Thus, to understand whether increased eIF6 levels restricted to cone cells affects 8 eye morphology we overexpressed eIF6 under the control of the cone cell specific driver, spaGAL4. We observed a similar phenotype to that of GMR>eIF6, albeit a milder one (Fig. 4a-b and Supplementary Fig. 4a ). Importantly, eIF6 overexpression specifically in cone cells, caused absence of Dcp-1 staining in 40h APF retinae ( Fig.   4c and Supplementary Fig. 4b ), confirming a block in apoptosis. In contrast, apoptosis was evident at 60h APF (Fig. 4d) (Fig. 5 ). In GMR>eIF6 samples at both developmental stages, we observed an upregulation of genes involved in ribosome biogenesis (Fig. 5a , Supplementary File 1). GSAA analysis revealed also an increase in mRNAs of genes involved in rRNA processing (Fig. 5c ). Overall these data suggest that eIF6 is able to increase ribosomal gene expression.
Consistent with our phenotypic analysis of the eye, GMR>eIF6 retinae displayed also variations in genes involved in eye development and in PCD ( 
Increasing eIF6 gene dosage results in elevated translation
eIF6 binds free 60S in vitro and in vivo affecting translation 7 . To assess whether increased transcription of genes related to ribosome biogenesis and rRNA processing observed in gene expression analysis experiments was accompanied by an effect in the translational machinery, we investigated changes in levels of free 60S subunits upon eIF6 overexpression. To this end, we performed the in vitro Ribosome Interaction Assay (iRIA) 33 . We found that the expression of eIF6 in larval eye discs (GMR>eIF6) led to a 25% reduction in free 60S sites when compared to control (GMRGAL4/+) (Fig 6a) . Next, we used a modified SUnSET assay 34 , as a proxy of the translational rate. We measured translation in eye imaginal discs treated ex vivo with puromycin, which incorporates in nascent protein chains by ribosomes.
Remarkably, GMR>eIF6 eye discs incorporated almost twice the amount of puromycin, relative to controls ( Fig. 6b-c ). Taken together, high levels of eIF6 increase the free 60S pool in vivo, and increase puromycin incorporation, i.e.
translation. We next determined whether the observed effects were specific of eye development or rather a more general outcome associated with increased eIF6 gene dosage. Thus, we overexpressed eIF6 in a different epithelial organ, the wing imaginal disc, using the bxMS1096GAL4 driver (MS>eIF6). Such manipulation led to complete disruption of the adult wing structure ( Fig. 6d and Supplementary Fig. 6c ).
Moreover, we performed the SUnSET assay on wing imaginal discs, and, as in eye discs, we observed a two-fold increase in puromycin incorporation in MS>eIF6 wing discs with respect to the controls ( Fig. 6e and Supplementary Fig. 6a ). Finally, eIF6
overexpression in wing discs led to the presence of apoptotic cells in the dorsal portion of the disc (Supplementary Fig. 6b ), as previously evidenced in the developing retina. In conclusion, the increased gene dosage of eIF6 leads to augmented translational activity that results in a specific gene expression program.
20-HE administration rescues adult eye defects induced by increased eIF6 gene dosage
Transcriptome analysis revealed a coordinated shutdown of the 20-HE biosynthetic pathway raising the question whether 20-HE administration could at least partly rescue the defects driven by eIF6 increased levels, and a rough eye phenotype characterized by aberrant PCD. To determine the hierarchy of events that the increased eIF6 gene dosage causes, we administrated the active form of the hormone 20-HE by feeding GMR>eIF6 third instar larvae with 20-HE and we evaluated the effect on eye development, finding a partial rescue of the rough phenotype. Remarkably, GMR>eIF6 larvae fed with 20-HE showed eyes that were 20% larger than untreated controls, although they remained smaller with respect to GMRGAL4/+ (Fig. 7a) . We also assessed the levels of apoptosis at 40h APF.
Notably, immunofluorescence staining for Dcp-1 showed the presence of apoptotic cells in 40h APF GMR>eIF6 retinae treated with 20-HE, while GMR>eIF6 untreated retinae did not show any Dcp-1 positive cells (Fig. 7b) . Taken toghether, these data suggest that the apoptotic defect and eye roughness caused by increased eIF6 gene dosage are due to the inactivation of ecdysone signaling, that precedes a deregulation of PCD.
eIF6 and translation antagonize ecdysone biosynthesis during development
Our findings indicate that increased eIF6 levels cause downregulation of mRNAs belonging to the ecdysone biosynthetic pathway, and the relative absence of its final product, the 20-HE. To understand the physiological relevance of this phenomenon,
we measured mRNAs levels of eIF6 and shd (as a proxy of the entire ecdysone biosynthetic pathway) which encodes for the last enzyme of the 20-HE biosynthesis, at different stages of development (Fig. 7) . We first confirmed by Real-Time PCR the downregulation of shd in eye imaginal disc overexpressing eIF6 (Fig. 7c) . We then investigated the levels of eIF6 and shd during development in wild-type tissues ( Fig. 7d-e). Interestingly, we found that eIF6 levels are regulated during development, and that shd levels drop when eIF6 levels are high, both by comparing embryos and first instar larvae (Fig. 7d ) or first and third instar larvae (Fig. 7e) . Taken together, data suggest that eIF6 gene dosage physiologically is inversely correlate with 20-HE production. To verify the inverse relationship between the translational rate and ecdysone production, we assessed levels of shd and EcR (as an index of the feed forward loop induced by 20-HE itself 35 ) mRNA levels in S2 cells after treatment with rapamycin or insulin to inhibit or stimulate translation respectively ( Fig. 7f-g ). After insulin treatment we observed the downregulation of shd and EcR mRNA levels ( Fig.   7f ). Conversely, after rapamycin treatment, which decreases mTORC1-regulated protein synthesis, we found an upregulation of the two analyzed genes (Fig. 7f) .
These data support a physiological model in which translation is a negative regulator of ecdysone metabolism.
DISCUSSION
Eukaryotic Initiation Factor eIF6 is an evolutionarily conserved gene encoding for a protein necessary for ribosome biogenesis and translation initiation 8, 9 . However, in mammals, eIF6 expression differs among tissues, with high levels in embryos and in cycling cells and almost undetectable levels in post-mitotic cells 15 . Developmental studies in mice demonstrated that null alleles for this initiation factor are incompatible with life 8 , whereas eIF6 haploinsufficiency is linked to an impairment in G1/S cell cycle progression 8 . In unicellular models, eIF6 mutations rescue the quasi-lethal phenotype due to loss of ribosome biogenesis factors such as SBDS 12 . Taken together, these data highlight how eIF6 expression, despite of its ubiquitous function, is strictly regulated. Indeed, we found that doubling levels of eIF6 during development disrupts eye morphology, increases translation and changes profoundly gene expression. Overall, our data demonstrate that eIF6 is a translation factor able to drive a complex transcriptional reshaping.
Mechanistically, eIF6 binds to the 60S in the intersubunit space, interacting with rpL23 and to the sarcin-loop (SRL) of rpL24 36 , thus generating a steric hindrance that prevents the formation of a intersubunit bridge 37 . In vitro, eIF6 can repress translation 38 . In mice, however, high levels of eIF6 are required for both tumor progression 18 , and insulin-controlled translation 7, 8 . In Drosophila, we found that an overexpression of eIF6 leads to a reduction of the free 60S pool in eye imaginal discs, consistent with eIF6 biochemical activity. Such reduction could imply lower general translation, due to less availability of 60S subunits, as in the case of Sbds mutants 39 . Conversely, 60S could be already engaged with 40S into active translating 80S, thus heightening general translation. We favor the latter hypothesis because by puromycin incorporation assay we see a two-fold increase in general translation, both in the developing eye and in the wing. Intriguingly, the transcriptome signature associated with high levels of eIF6 revealed also an increase in mRNAs encoding for rRNA processing factors, suggesting that ribosome biogenesis is positively affected by eIF6. In conclusion, we surmise that in vivo eIF6 may act as a powerful stimulator of ribosome synthesis and translation. The effects associated with increased translation driven by eIF6 are at least two, a change in the ecdysone pathway and a delay in apoptosis. We found a strong reduction of ecdysone biosynthesis and signaling pathway in eye imaginal disc driven by eIF6. 20-HE treatment leads to a partial rescue of the developmental defects driven by eIF6 increased activity. Thus, our data suggest that eIF6 is upstream of ecdysone The developmental changes due to eIF6-driven translation are dramatic and include lethality, as well as disruption of development. In the past, similar effects were observed by the expression of another rate-limiting factor in translational initiation, eIF4E 43 . It is unknown whether the developmental defects driven by eIF4E
overexpression also included the arrest of ecdysone biosynthetic pathway, or an apoptotic block. However, in mammalian models eIF4E and eIF6 share the common property of being rate-limiting for tumor growth and translation in several contexts [44] [45] [46] [47] [48] [49] [50] . In summary, our study demonstrates that overexpression of eIF6 in developing organs is sufficient to induce an increase in ribosome biogenesis and translation that correlates with complex transcriptional and metabolic changes leading to hormonal and apoptotic defects. It will be interesting to further dissect the relationship between epigenetic, metabolic, and transcriptional changes in the Drosophila model. Our model may also be useful for in vivo screenings of compounds that suppress the effect of eIF6 overexpression. Such approach could isolate useful therapeutics that might be relevant to the protumourigenic role of mammalian eIF6, and could identify novel genetic modulators of eIF6 function. In short, translation factors may drive
MATERIALS AND METHODS
Genetics
Fly strains were maintained on standard cornmeal food at 18°C. 53 .
Gene expression quantification and differential expression analysis.
HTSeq-count algorithm (version 0.6.1, option -s = no, gene annotation release 79 from Ensembl) 54 was employed to produce gene counts for each sample. To estimate differential expression, the matrix of gene counts produced by HTSeq was analyzed by DESeq2 (version DESeq2_1.12.4) 55 . The differential expression analysis by the DeSeq2 algorithm was performed on the entire dataset composed by both larvae and pupae samples. The two following comparisons were analyzed:
GMR>eIF6 versus GMRGAL4/+ larval eye imaginal discs (6 samples overall) and
GMR>eIF6 versus GMRGAL4/+ pupal retinae (8 samples in total). Reads counts
were normalized by calculating a size factor, as implemented in DESeq2.
Independent filtering procedure was then applied, setting the threshold to the 62 percentile; 10886 genes were therefore tested for differential expression.
Significantly modulated genes in GMR>eIF6 genotype were selected by considering a false discovery rate lower than 5%. 
Functional analysis by topGO
The Gene Ontology enrichment analysis was performed using topGO R Bioconductor package (version topGO_2.24.0). The option nodesize = 5 is used to prune the GO hierarchy from the terms which have less than 5 annotated genes and the annFUN.db function is used to extract the gene-to-GO mappings from the genome-wide annotation library org.Dm.eg.db for D. melanogaster. The statistical enrichment of GO was tested using the Fisher's exact test. Both the "classic" and "elim" algorithms were used.
Gene set association analysis
Gene set association analysis for larvae and pupae samples was performed by GSAA software (version 2.0) 56 .
Raw reads for 10886 genes identified by Entrez
Gene ID were analyzed by GSAASeqSP, using gene set C5 (Drosophila version retrieved from http://www.go2msig.org/cgi-bin/prebuilt.cgi?taxid=7227) and specifying as permutation type 'gene set' and as gene set size filtering min 15 and max 800.
Western blotting and antibodies
Larval imaginal discs, pupal retinae and adult heads were dissected in cold Phosphate Buffer Saline (Na 2 HPO 4 
SUnSET Assay
Larval imaginal eye and wing discs were dissected in complete Schneider medium (Lonza, Basel, Switzerland) and treated ex vivo with puromycin (50 µg/mL) for 30 minutes at room temperature, then fixed in 3% paraformaldehyde (PFA) for 1 hour at room temperature. Immunofluorescences were then performed as described below, using a mouse anti-puromycin (1:500, Merck Millipore, Billerica, MA, USA, #MABE343) as a primary antibody. Discs were then examined by confocal microscope (Leica SP5, Leica, Wetzlar, Germany) and fluorescence intensity was measured with ImageJ software.
Cells count
GMRGAL4/+ and GMR>eIF6 pupal retinae at 40h APF were dissected, fixed, and stained with anti-Armadillo to count cells, as previously described 57 . Cells contained within a hexagonal array (an imaginary hexagon that connects the centers of the surrounding six ommatidia) were counted; for different genotypes, the number of cells per hexagon was calculated by counting cells, compared with corresponding control. Cells at the boundaries between neighboring ommatidia count half. At least 3
hexagons (equivalent to 9 full ommatidia) were counted for each genotype, and phenotypes were analysed. Standard Deviation (SD) and unpaired two-tailed Student t-test were used as statistical analysis.
Immunofluorescences, antibodies and TUNEL Assay
Larval imaginal discs and pupal retinae were dissected in cold PBS and fixed in 3% 
Semithin sections
Semithin sections were prepared as described in 58 . Adult eyes were fixed in 0.1 M Sodium Phosphate Buffer, 2% glutaraldehyde, on ice for 30 min, then incubated with 2% OsO 4 in 0.1 M Sodium Phosphate Buffer for 2 hours on ice, dehydrated in ethanol (30%, 50%, 70%, 90%, and 100%) and twice in propylene oxide. Dehydrated eyes were then incubated O/N in 1:1 mix of propylene oxide and epoxy resin (Sigma, Durcupan™ ACM). Finally, eyes were embedded in pure epoxy resin and baked O/N at 70°C. The embedded eyes were cut on a Leica UltraCut UC6 microtome using a glass knife and images were acquired with a 100X oil lens, Nikon Upright XP61 microscope (Nikon, Tokyo, Japan).
Ecdysone treatment
For ecdysone treatment, 20-HydroxyEcdysone (20HE) (Sigma, #H5142) was dissolved in 100% ethanol to a final concentration of 5 mg/mL; third instar larvae from different genotypes (GMRGAL4/+ and GMR>eIF6) were collected and placed in individual vials on fresh standard cornmeal food supplemented with 240 µg/mL 20-HE. Eye phenotype was analyzed in adult flies, and images were captured with a TOUPCAM™ Digital camera. Eye images were analyzed with ImageJ software.
In vitro Ribosome Interaction Assay (iRIA)
iRIA assay was performed as described in 
Data availability
Data generated by our RNASeq experiment have been deposited in ArrayExpress.
Accession Number ID will be provided upon acceptance for publication. 
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